|
Volumn 18, Issue SUPPL. E, 1986, Pages 193-202
|
The safety profile of imipenem/cilastatin: Worldwide clinical experience based on 3470 patients
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CILASTATIN;
IMIPENEM;
ADVERSE DRUG REACTION;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
BLEEDING TENDENCY;
BLOOD AND HEMOPOIETIC SYSTEM;
CENTRAL NERVOUS SYSTEM;
CLINICAL EXAMINATION;
CONVULSION;
COOMBS TEST;
DIGESTIVE SYSTEM;
DRUG HYPERSENSITIVITY;
DRUG MIXTURE;
DRUG SAFETY;
DRUG THERAPY;
EOSINOPHILIA;
GASTROINTESTINAL SYMPTOM;
GASTROINTESTINAL TOXICITY;
HUMAN;
INTOXICATION;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY;
LABORATORY TEST;
LARGE INTESTINE;
LIVER TOXICITY;
NEPHROTOXICITY;
NERVOUS SYSTEM;
NEUROTOXICITY;
PERIPHERAL VASCULAR SYSTEM;
PHLEBITIS;
PRIORITY JOURNAL;
PSEUDOMEMBRANOUS COLITIS;
REVIEW;
SKIN ALLERGY;
SKIN TOXICITY;
THERAPY;
THROMBOCYTOSIS;
|
EID: 0022971332
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: 10.1093/jac/18.supplement_e.193 Document Type: Article |
Times cited : (70)
|
References (0)
|